These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 8806518)
1. Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection. Alin K; Goff SP Virology; 1996 Aug; 222(2):339-51. PubMed ID: 8806518 [TBL] [Abstract][Full Text] [Related]
2. Substitution mutations affecting a small region of the Moloney murine leukemia virus MA gag protein block assembly and release of virion particles. Granowitz C; Goff SP Virology; 1994 Nov; 205(1):336-44. PubMed ID: 7975229 [TBL] [Abstract][Full Text] [Related]
3. Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. Gonsky J; Bacharach E; Goff SP J Virol; 2001 Mar; 75(6):2616-26. PubMed ID: 11222684 [TBL] [Abstract][Full Text] [Related]
4. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication. Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338 [TBL] [Abstract][Full Text] [Related]
5. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity. Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910 [TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus. Fisher J; Goff SP Virology; 1998 Apr; 244(1):133-45. PubMed ID: 9581786 [TBL] [Abstract][Full Text] [Related]
7. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity. Housset V; Darlix JL C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959 [TBL] [Abstract][Full Text] [Related]
8. Cis-acting elements required for strong stop acceptor template selection during Moloney murine leukemia virus reverse transcription. Topping R; Demoitie MA; Shin NH; Telesnitsky A J Mol Biol; 1998 Aug; 281(1):1-15. PubMed ID: 9680471 [TBL] [Abstract][Full Text] [Related]
9. Point mutations in Moloney murine leukemia virus envelope protein: effects on infectivity, virion association, and superinfection resistance. Berkowitz RD; Goff SP Virology; 1993 Oct; 196(2):748-57. PubMed ID: 8372445 [TBL] [Abstract][Full Text] [Related]
10. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro. VanBrocklin M; Federspiel MJ Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188 [TBL] [Abstract][Full Text] [Related]
11. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1. Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884 [TBL] [Abstract][Full Text] [Related]
12. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. Lapadat-Tapolsky M; Gabus C; Rau M; Darlix JL J Mol Biol; 1997 May; 268(2):250-60. PubMed ID: 9159468 [TBL] [Abstract][Full Text] [Related]
13. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo. Yu Q; Darlix JL J Virol; 1996 Sep; 70(9):5791-8. PubMed ID: 8709195 [TBL] [Abstract][Full Text] [Related]
14. Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: rapid reversion during replication. Granowitz C; Berkowitz RD; Goff SP Virus Res; 1996 Mar; 41(1):25-42. PubMed ID: 8725100 [TBL] [Abstract][Full Text] [Related]
15. Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo. Gorelick RJ; Benveniste RE; Gagliardi TD; Wiltrout TA; Busch LK; Bosche WJ; Coren LV; Lifson JD; Bradley PJ; Henderson LE; Arthur LO Virology; 1999 Jan; 253(2):259-70. PubMed ID: 9918884 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer. Mbisa JL; Nikolenko GN; Pathak VK J Virol; 2005 Jan; 79(1):419-27. PubMed ID: 15596835 [TBL] [Abstract][Full Text] [Related]
17. The role of nucleocapsid of HIV-1 in virus assembly. Dawson L; Yu XF Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210 [TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. Tang S; Murakami T; Agresta BE; Campbell S; Freed EO; Levin JG J Virol; 2001 Oct; 75(19):9357-66. PubMed ID: 11533199 [TBL] [Abstract][Full Text] [Related]
19. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. Tanese N; Telesnitsky A; Goff SP J Virol; 1991 Aug; 65(8):4387-97. PubMed ID: 1712862 [TBL] [Abstract][Full Text] [Related]
20. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein. Thomas A; Gray KD; Roth MJ Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]